Latest Trials

Multiple treatment types

KEYNOTE-799 : A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III...

This phase II trial is testing a drug (pembrolizumab) in combination with chemotherapy and radiotherapy for the treatment of locally advanced Stage III non-small cell lung cancer that cannot be removed by surgery

Status : Recruiting

Systemic therapy trial

KEYNOTE-789 : A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or...

This phase III trial is evaluating a chemotherapy combination (pemetrexed combined with carboplatin or cisplatin) with and without the drug KEYTRUDA® (pembrolizumab) for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC)

Status : Recruiting

Systemic therapy trial

Resilient : A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) Versus...

This phase II/III trial is comparing two intravenous drugs (Irinotecan liposome injection and Topotecan injection) in patients with small cell lung cancer who have gotten worse after first line therapy

Status : Recruiting

Systemic therapy trial

A Phase 1, First-in-Human, Open-label Study Evaluating the Safety, Tolerability,...

This phase I trial is trying to find the optimal dose of an oral drug (AMG 510) to treat patients with advanced cancers with a specific KRAS mutation

Status : Recruiting

Systemic therapy trial

HLX20 : A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting Programmed Death Ligand 1...

This phase I trial is testing a new drug (HLX20) for people whose cancer has spread or come back following prior therapy

Status : Recruiting

Systemic therapy trial

Morpheus-CRC : A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy...

This phase Ib/II trial is evaluating different combinations of immunotherapy-based treatments in patients with metastatic colorectal cancer that has not responded or gotten worse on other treatments

Status : Recruiting

Systemic therapy trial

MYPHISMO : First-in-human Phase I Clinical Trial of a Combined Immune Modulatory Approach Using...

This phase I trial is looking at the effects of two immunotherapies (TetMYB Vaccine in combination with BGB-A317) in patients with advanced cancers ( including colorectal and adenoid cystic cancer) that may have spread to other parts of the body

Status : Recruiting

Systemic therapy trial

A Phase I/Ib, Open-label, Multi-center, Study of NZV930 as a Single Agent and in...

This phase I trial is evaluating a new intravenous drug (NZV930) alone and in combination with two other drugs (one intravenous and one oral) for the treatment of specific advanced cancers

Status : Recruiting

Systemic therapy trial

A Phase 1, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety,...

This phase I trial is evaluating a new biological therapy (MEDI5752) alone and in combination with various chemotherapy / immunotherapy drugs for the treatment of advanced solid cancers

Status : Recruiting

Systemic therapy trial

An Open-Label, Multi-center, Dose-Escalation Phase I Study to Evaluate Safety,...

This phase I trial is testing a new drug (KN046) in patients with advanced cancers who are not able to have any other standard therapies

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.